Because the EGFR gene is overexpressed in 80% of cervical cancer tumors, an anti-viral targeting E6/E7/E5 oncoproteins or related signaling pathways, such as an anti-EGFR agent, can play a critical role in preventing cancer progression (105, 106). This evidence concerns the gene EGFR and cancer.